VEGF Trap-Eye To Be Tested in Clinical Trial in Asia

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Regeneron Commences Clinical Trial of Efficacy and Safety of VEGF Trap-Eye in Patients With Choroidal Neovascularisation (CNV) of the Retina

Posted By Dr. Ari Weitzner On January 20, 2011 @ 3:40 am In Research,Retina | Comments Disabled

Regeneron and Bayer HealthCare recently announced initiation of a new Phase 3 clinical trial in collaboration with the Singapore Eye Research Institute (SERI) to investigate the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic solution) in patients with choroidal neovascularisation (CNV) of the retina as a result of pathologic myopia. The trial has started in Japan and other Asian countries, including China, Korea, Singapore, and Taiwan.

Read the full press release ^[1].

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/004701-regeneron-commences-clinical-trial-of-efficacy-and-safety-of-vegf-trap-eye-in-patients-with-choroidal-neovascularisation-cnv-of-the-retina/

URLs in this post:

[1] Read the full press release: http://newsroom.regeneron.com/releasedetail.cfm?ReleaseID=544094

Click here to print.